More on reports of esophageal cancer with oral bisphosphonate use.
Abrahamsen
Bo
B
Eiken
Pia
P
Eastell
Richard
R
D000284:Administration, Oral; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D016001:Confidence Intervals; D004164:Diphosphonates / Q000009:adverse effects*; D004938:Esophageal Neoplasms / Q000139:chemically induced*; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000188:drug therapy; D006801:Humans; D016016:Proportional Hazards Models; D018570:Risk Assessment; D013274:Stomach Neoplasms / Q000139:chemically induced*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates